![surpass 4 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Tirzepatide Matches Dulaglutide in Large](https://www.researchgate.net/publication/363201315/figure/fig3/AS:11431281082605778@1662084799021/Efficacy-of-tirzepatide-in-phase-2-GPGB-14-and-phase-3-SURPASS-1-to-5-15-19.png)
Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Not for Type 1 Diabetes or Diabetic Ketoacidosis: Ozempic is not approved for use in type 1 diabetes or for treating diabetic ketoacidosis, as it is not effective for these conditions
![surpass 4 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Tirzepatide Matches Dulaglutide in Large](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/styles/header_image/public/2025-07/Tirzepatide%20Matches%20Dulaglutide%20in%20Large%20CV%20Outcomes%20Trial%20SURPASS-CVOT.jpg?itok=ZFQ7unis)
Our services range from ozempic injection therapy to botox treatment and more
![surpass 4 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Tirzepatide Matches Dulaglutide in Large](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-022-01733-2/MediaObjects/41591_2022_1733_Fig1_HTML.png)
Injection timing and missed doses should be managed according to FDA guidelines
![surpass 4 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Tirzepatide Matches Dulaglutide in Large](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41591-025-04102-x/MediaObjects/41591_2025_4102_Fig1_HTML.png)
With the growing healthcare infrastructure, the region is experiencing a surge in middle class population, high awareness about advanced therapies and new opportunities for investment have boosted market growth
![surpass 4 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Tirzepatide Matches Dulaglutide in Large](http://bloommd.com/cdn/shop/files/ChatGPT_Image_May_3_2026_08_42_37_AM.png?v=1777819401)
Clinical evidence The STEP 1 trial showed participants achieved an average 14.9% weight loss over 68 weeks with semaglutide 2.4 mg
![surpass 4 tirzepatide Efficacy of in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1 Tirzepatide Matches Dulaglutide in Large](http://gpvoice.com.au/wp-content/uploads/2023/09/SURPASSTrials-1024x771.png)
US$ 23.44
US$ 20.30
US$ 23.58
US$ 27.11
US$ 26.43
US$ 26.42
:max_bytes(150000):strip_icc()/insulin-injection-478185779-594b3cae3df78cae8111498f.jpg)
US$ 21.22
US$ 29.64
US$ 20.55
US$ 28.84
